“Thursday 21 November 2019- The BC Centre for Excellence in HIV/AIDS (BC-CfE) released results from its Provincial BOOST (Best Practices in Oral Opioid AgoniSt Therapy) Collaborative today, revealing an increase in the number of British Columbians being treated for opioid use disorder (OUD).
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
